It is suggested that AD occurs mainly by binding amyloid plaques to insulin cell receptors, inhibiting intracellular insulin signaling, causing insulin resistance, and ultimately altering glucose metabolism and amyloid clearance (2). This evidence concerns the gene INS and Alzheimer disease.